Home NDC 70121-1647 Tigecycline
Product NDC 70121-1647
11-digit product format 701211647
Labeler code 70121
Product ID 70121-1647_c21de58f-dcd0-46f7-a6d9-0ff5ba5863a1
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Tigecycline
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Amneal Pharmaceuticals LLC
Application NDA211158
Marketing category NDA
Marketing start 2018-01-31
Substance TIGECYCLINE
Active strength 50 mg/5mL
Pharmacologic classes Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N211158-001 TIGECYCLINE TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N211158-001 AP
Orange Book patents# Current patent rows page 1 of 1 · 1 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N211158-001 9855335 2033-04-07 Drug product 2018-09-19
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS 2018-08-02 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N211158-001 TIGECYCLINE 50MG/VIAL POWDER / INTRAVENOUS AP 2018-08-02 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
Observed Orange Book patent history# Patent history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N211158-001 9855335 2033-04-07 Drug product 2018-09-19 e64feba35796…
Additional Listing Data#
Finished product Yes
Brand name base Tigecycline
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TIGECYCLINE 50 mg/5mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 70JE2N95KR Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 581531 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70121-1647-1 Tigecycline 5 mL in 1 VIAL INJECTION, POWDER, LYOPHILIZED, 5 19 70121-1647-7 Tigecycline 10 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 10 19
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 70121-1647 TIGECYCLINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [AMNEAL PHARMACEUTICALS LLC] 19 Current NDC, Legacy NDC, 2 package rows 20250403_8450bd15-2b06-4fc7-b302-9021312e3f0d.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 70121-1647-1 70121164701 5 mL in 1 VIAL 5 ml Historical 70121-1647-7 70121164707 10 VIAL in 1 CARTON (70121-1647-7) / 5 mL in 1 VIAL (70121-1647-1) 10 vial 2018-01-31 0000-00-00 No No Current